Stock Market Update
13-Apr-26 08:25 ET
Futures point to lower open as U.S. and Iran fail to strike agreement
Market is Closed
[BRIEFING.COM] S&P futures vs fair value: -44.00. Nasdaq futures vs fair value: -160.00.
The S&P 500 futures currently 44 trade points below fair value.
Revolution Medicines (RVMD 132.91, +36.48, + 37.8%) is trading sharply higher in the premarket after reporting positive topline results from its Phase 3 trial evaluating daraxonrasib. The study showed that pancreatic cancer patients receiving the daily oral therapy achieved statistically significant and clinically meaningful improvements in both progression-free survival (PFS) and overall survival (OS) versus standard-of-care intravenous cytotoxic chemotherapy.
On the geopolitical front, Axios reports that mediators from various countries will continue talks with the U.S. and Iran in an effort to resolve disagreements.
